Active	Status	Sponsor type	Region	Phase	Filter
5 Active 5 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
PLANTIER, Laurent
NCT03939520 / 2019-004326-19: Management of Progressive Disease in Idiopathic Pulmonary Fibrosis	Recruiting	4	378	Europe	pirfenidone and nintedanib, pirfenidone or nintedanib	Hospices Civils de Lyon, Ministry of Health	Progressive Idiopathic Pulmonary Fibrosis	01/26	01/26
NCT05532995: Responses to CPET in Subjects With Persistent Exercise Intolerance After COVID-19: an Open-Source Exercise Network	Completed	N/A	1200	Europe, Canada, RoW		Association pour la Complementarite des Connaissances et des Pratiques de la Pneumologie, Menarini Group, Hylab, Grenoble, AstraZeneca	COVID-19	12/23	12/23
AEROPERC, NCT05366387: Effect of Intrapulmonary Percussion Ventilation on Deposition of Inhaled Aerosols in Idiopathic Pulmonary Fibrosis	Recruiting	N/A	10	Europe	intrapulmonary percussive ventilation, delivery of 99mTc-DTPA aerosol	University Hospital, Tours, Institut National de la Santé Et de la Recherche Médicale, France	Idiopathic Pulmonary Fibrosis	05/24	05/24
BARRIG, NCT06670937: Role of BARriers in IgG-Pathogen Interactions At the Mucosal Surface in Human Airways	Not yet recruiting	N/A	30	Europe	Induced sputum, Blood sample	University Hospital, Tours	Bronchiectasis Adult	01/26	01/26
Andres-Rieth, Lara
NCT05532995: Responses to CPET in Subjects With Persistent Exercise Intolerance After COVID-19: an Open-Source Exercise Network	Completed	N/A	1200	Europe, Canada, RoW		Association pour la Complementarite des Connaissances et des Pratiques de la Pneumologie, Menarini Group, Hylab, Grenoble, AstraZeneca	COVID-19	12/23	12/23